Two Landmark Studies Shed New Light–and Shadow– on Omega-3s for CVD
By William H. Harris, PhD, Contributing Writer
Two pivotal studies on omega-3s —the long awaited REDUCE-IT and VITAL trials, attempt to clarify the clinical roles of omega-3s for cardiovascular risk reduction. While many of the mainstream headlines took a negative view of the findings, the data actually show some meaningful benefits from omega-3s. Dr. Bill Harris, developer of the Omega-3 Index test, weighs in on the negative and positive messags of these important studies.
Read more ...
Resveratrol, a polyphenolic compound found in red wine and widely touted for its antioxidant and cell signaling effects, also improves insulin sensitivity, according to a recent study by researchers at the Albert Einstein College of Medicine, Bronx, NY.
